Alde Medi Impex Ltd.
SMEBSETBA
TBA
1 Shares
TBA
₹10
Subscription Details
IPO Timeline
IPO Offer Start
TBA
IPO Offer Ends
TBA
TBA
Use of Proceeds
| # | Purpose | Amount (₹ Million) |
|---|---|---|
| 1 | Repayment and/or pre-payment, in full or part, of certain | 33.646 |
| 2 | To meet working capital requirements | 353.236 |
Promoters
Book Running Lead Managers
Promoter Shareholding
Pre-IPO
98.62%
Promoter stake
Offered to Public
47,28,000
shares
About the Company
We are engaged in the marketing, branding, distribution of pharmaceutical and nutraceutical products. Our activities encompass product identification and development, sourcing, manufacturing coordination, product registrations, regulatory compliance, quality assurance, branding, marketing, sales and distribution across domestic and international markets. The products marketed and distributed by us comprises of prescription-based (ethical) products, over-the-counter (OTC) / generic products, critical care products and nutraceutical products across various dosage form such as tablets, capsules, injections, syrups, dry syrups, powder, ointments, creams and drops. The products we market and distribute caters to various therapeutic categories, including anti-infectives, cardiology, critical care, gastroenterology, gynaecology, metabolic disorders, neurology and central nervous system, nutraceuticals, ophthalmology, orthopaedics and paediatrics, among others. As on the March 31, 2026, our Company deals in more than 800 products across various therapeutic categories marketed across our domestic and international markets.
Use of Proceeds
1) Repayment and/or pre-payment, in full or part, of certain borrowings availed by our Company. 2) To meet working capital requirements 3) General Corporate Purposes.
Alde Medi Impex Ltd. Latest News
News
No news found for Alde Medi Impex Ltd..